GlassScriptPhysician profile
Anthony Massoll
NPI 1932669967
$6,995.03
in general payments reported to CMS, 2019-2025
8 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,916 · 2024: $3,409 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,912 · Travel and Lodging: $2,416 · Grant: $1,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,912.42 |
| Travel and Lodging | $2,415.61 |
| Grant | $1,667.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,155.18 | 2023-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Abbott Laboratories | $2,187.05 | 2023-2025 | Proclaim, Eterna, Axium |
| Boston Scientific Corporation | $296.44 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Globus Medical, INC. | $161.87 | 2025 | Senza |
| Spr Therapeutics, INC | $90.76 | 2023-2024 | Sprint Pns System |
| Mml US, INC. | $56.00 | 2023-2025 | Reactiv8 |
| Saluda Medical Americas, INC. | $27.89 | 2024 | Evoke |
| Biotronik Nro, INC. | $19.84 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Massoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.